Biogen (BIIB)

Biogen (BIIB) Stock Price & Analysis


BIIB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$188.54 - $319.74
Previous Close$298.66
Average Volume (3M)907.81K
Market Cap
Enterprise Value$44.79B
Total Cash (Recent Filing)$5.04B
Total Debt (Recent Filing)$6.61B
Price to Earnings (P/E)13.9
Jul 25, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)21.54
Shares Outstanding144,742,305
10 Day Avg. Volume704,658
30 Day Avg. Volume907,812
Standard Deviation0.11
Financial Highlights & Ratios
Price to Book (P/B)7.00
Price to Sales (P/S)24.52
Price to Cash Flow (P/CF)24.00
P/FCF Ratio21.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.76
Enterprise Value/Gross Profit5.94
Enterprise Value/Ebitda10.51
Price Target Upside10.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Biogen’s price range in the past 12 months?
Biogen lowest stock price was $188.53 and its highest was $319.74 in the past 12 months.
    What is Biogen’s market cap?
    Currently, no data Available
    When is Biogen’s upcoming earnings report date?
    Biogen’s upcoming earnings report date is Jul 25, 2023 which is in 57 days.
      How were Biogen’s earnings last quarter?
      Biogen released its earnings results on Apr 25, 2023. The company reported $3.4 earnings per share for the quarter, beating the consensus estimate of $3.278 by $0.122.
        Is Biogen overvalued?
        According to Wall Street analysts Biogen’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Biogen pay dividends?
          Biogen pays a Notavailable dividend of $22.23 which represents an annual dividend yield of N/A. See more information on Biogen dividends here
            What is Biogen’s EPS estimate?
            Biogen’s EPS estimate is $3.75.
              How many shares outstanding does Biogen have?
              Biogen has 144,742,310 shares outstanding.
                What happened to Biogen’s price movement after its last earnings report?
                Biogen reported an EPS of $3.4 in its last earnings report, beating expectations of $3.278. Following the earnings report the stock price went down -3.624%.
                  Which hedge fund is a major shareholder of Biogen?
                  Among the largest hedge funds holding Biogen’s share is PRIMECAP Management Co. It holds Biogen’s shares valued at 4B.


                    Biogen Stock Smart Score

                    The Biogen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description


                    Incorporated in 1978, Massachusetts-based Biogen, Inc. is a biopharmaceutical company, which discovers, develops, and delivers therapies for the treatment of neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, VUMERITY, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis.


                    Top 5 ETFs holding BIIB

                    Market Value
                    Smart Score
                    Vanguard S&P 500 ETF
                    Invesco QQQ Trust
                    SPDR S&P 500 ETF Trust
                    SPDR S&P 500 ETF Trust CDI
                    iShares Core S&P 500 ETF
                    Up to five ETFs with an Outperform Smart Score that hold BIIB. The ETFs are listed according to market value of BIIB within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Gilead Sciences
                    Vertex Pharmaceuticals

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis